In a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort which included 1,976 incident invasive breast cancers and the same number of controls, Sarink et al., evaluated circulating RANKL (and RANKL/OPG) with breast cancer risk [12]. This evidence concerns the gene TNFRSF11B and breast carcinoma.